Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 16 Carcinoma, Non-Small-Cell Lung 7 Ovarian Neoplasms 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Pancreatic Intraductal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Thrombosis 1 Stage IA Uterine Sarcoma 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Solid Tumor Cancer 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Peripheral Nervous System Diseases 1 Pancreatic Cyst 1 Pain 1 Organoid 1 Neoplasms, Germ Cell and Embryonal 1 NSCLC 1 Motor Activity 1 Medulloblastoma 1 Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer 1

Interventions

sugemalimab 1 spartalizumab 1 Vinorelbine 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Liquid Biopsy 1 Gemcitabine 1 Gefitinib 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Docetaxel 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NSCLC × Paclitaxel × Clear all

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡